EGF and breast cancer: P38 is a reported substrate of PTK6 that is critical for proliferation and Heregulin-induced migration of breast cancer cells.43 In these studies, PTK6 downregulation inhibited EGF or Heregulin-induced phosphorylation of p38 MAPK.